These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30083074)

  • 1. Kala-Azar and leukemia: A rare association.
    Bay A; Aktekin EH; Ekşi F; Özcan M
    Turk Pediatri Ars; 2018 Mar; 53(1):45-47. PubMed ID: 30083074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Hematological Features of Visceral Leishmaniasis at Mymensingh Medical College Hospital.
    Malek MS; Robi IH; Islam MS; Kabir MA; Uddin MZ; Sumon SM; Siddiqui NI
    Mymensingh Med J; 2020 Oct; 29(4):879-886. PubMed ID: 33116091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic changes in visceral leishmaniasis/kala azar.
    Varma N; Naseem S
    Indian J Hematol Blood Transfus; 2010 Sep; 26(3):78-82. PubMed ID: 21886387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Visceral leishmaniasis (kala-azar). A rare differential diagnosis of splenomegaly and pancytopenia].
    Baldus M; Schleiffer T; Brass H
    Dtsch Med Wochenschr; 1989 Dec; 114(48):1876-81. PubMed ID: 2555125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S; Bajracharya BL; Baral MR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kala-azar associated with coombs-positive autoimmune hemolytic anemia in the patients coming from the endemic area of this disease and successful treatment of these patients with liposomal amphotericin B.
    Erduran E; Bahadir A; Gedik Y
    Pediatr Hematol Oncol; 2005; 22(5):349-55. PubMed ID: 16020124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral leishmaniasis-associated hemophagocytosis: a single center experience.
    Mokhtari M; Kumar PV
    Arch Iran Med; 2013 Aug; 16(8):471-3. PubMed ID: 23906252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral leishmaniasis (kala-azar) after a visit to the Mediterranean region.
    Rudi J; Racz P; Hörner M; Kommerell B
    Clin Investig; 1993 Aug; 71(8):616-9. PubMed ID: 8219656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child.
    Meinecke CK; Schottelius J; Oskam L; Fleischer B
    Pediatrics; 1999 Nov; 104(5):e65. PubMed ID: 10545591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Co-existence of Kala-azar and salmonellosis in a 16 month-old baby? Or a false positive widal reaction in Kala-azar?].
    Kayserılı E; Hizarcioğlu M; Gülez P; Apa H; Keskın S
    Turkiye Parazitol Derg; 2005; 29(3):141-4. PubMed ID: 17160808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rare Presentation of Leishmaniasis.
    Prajapati R; Kumar A; Sharma P; Singla V; Bansal N; Dhawan S; Arora A
    J Clin Exp Hepatol; 2016 Jun; 6(2):146-8. PubMed ID: 27493461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infantile visceral leishmaniasis, an etiology of easily curable hemophagocytic lymphohistiocytosis syndrome].
    Visentin S; Baudesson de Chanville A; Loosveld M; Chambost H; Barlogis V
    Arch Pediatr; 2013 Nov; 20(11):1225-1229. PubMed ID: 24076317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
    Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
    Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imported and autochthonous kala-azar in France.
    Jeannel D; Tuppin P; Brucker G; Danis M; Gentilini M
    BMJ; 1991 Aug; 303(6798):336-8. PubMed ID: 1912774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CONSIDERATIONS ON THE DIAGNOSIS, PATHOGENESIS AND TREATMENT OF KALA-AZAR (MEDITERRANEAN VISCERAL LEISHMANIASIS)].
    GIRAUD P; BERNARD R; ORSINI A; COIGNET J; RAYBAUD C; LOUCHET E
    Arch Fr Pediatr; 1963; 20():803-10. PubMed ID: 14049368
    [No Abstract]   [Full Text] [Related]  

  • 16. Atypical presentation of visceral leishmaniasis (kala-azar) from non-endemic area.
    Singh Y; Singh P; Joshi SC; Khalil M
    WHO South East Asia J Public Health; 2014; 3(1):69-71. PubMed ID: 28607257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Haematological Parameters Associated With Visceral Leishmaniasis in Bangladeshi Individuals.
    Sarkar SR; Ray NC; Khan ER; Haque N; Hossain MA; Paul SK; Noiri E; Matsumoto Y; Sanjoba C
    Mymensingh Med J; 2018 Jul; 27(3):496-503. PubMed ID: 30141437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kala-azar in a four-year-old child 18 months after brief exposure in Malta.
    Ornvold K; Carstensen H; Magnussen P; Nielsen MH; Pedersen FK
    Acta Paediatr Scand; 1989 Jul; 78(4):650-2. PubMed ID: 2551125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated Leishmaniasis Due to Using Immunosuppression Drugs: A Case Report.
    Afshoon M; Abdolsalehi M; Alinia G; Borhani K; Yaghmaie B; Khodabandeh M
    Iran J Parasitol; 2020; 15(2):278-281. PubMed ID: 32595720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [KALA-AZAR].
    ORSINI A; RAYBAUD C; GIRAUD F
    Med Infant (Paris); 1964 Feb; 71():85-96. PubMed ID: 14140190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.